UnitedHealth Group Incorporated (NYSE:UNH) Director Purchases $93,648.00 in Stock

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) Director John H. Noseworthy purchased 300 shares of the stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares in the company, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

UnitedHealth Group Price Performance

Shares of UNH traded up $18.81 during mid-day trading on Friday, hitting $293.16. 56,876,207 shares of the company traded hands, compared to its average volume of 5,806,444. The business has a 50-day moving average of $474.72 and a 200 day moving average of $515.82. The stock has a market capitalization of $265.93 billion, a price-to-earnings ratio of 18.80, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the firm posted $6.91 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.87%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on UNH shares. Deutsche Bank Aktiengesellschaft cut their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday. Morgan Stanley cut their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday. HSBC reiterated a "hold" rating and issued a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Finally, Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price target for the company from $560.00 to $350.00 in a report on Wednesday. Six research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $486.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Norges Bank bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $6,375,744,000. GAMMA Investing LLC increased its position in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Nuveen LLC bought a new position in UnitedHealth Group during the first quarter worth $3,846,764,000. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $1,914,740,000. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.